Whole body PET/CT scan validation study
Part of Bones, joints & muscles, Cancer clinical trials.
This study tests a new way to read whole-body PET/CT scans to better find cancer in bones. It may help if you have a suspicious spot in your bone, high tumor markers, or your doctor thinks a scan is needed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a suspicious spot in your bone, high tumor markers in your blood, or your doctor says a scan is needed.
- You do not have an active infection at or near where a needle would go in.
- You do not have a severe bleeding problem that can't be fixed.
- Your random blood sugar is 11.1 mmol/L or lower.
- You are willing to have a tissue sample taken or follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new type of PET scan (a special imaging test) called 18F-FGIn to help doctors better detect and evaluate cancers. It may be more accurate than the standard PET scan for certain tumors like brain, liver, stomach, and colon cancers.
This trial tests whether a newer type of MRI scan (called whole-body DWI) can work as well as a standard PET/CT scan (called FDG PET) for finding and monitoring cancer that has spread. If you have metastatic cancer and already have a scheduled PET/CT or other scan, you may be able to get both scans done, helping researchers compare the two methods.
This study uses a CT scan to estimate how strong a cancer-affected bone area is, helping doctors evaluate fracture risk and bone management. It is aimed at adults with bone lesions from several common cancer types.
This trial uses a special PET scan to guide radiation therapy for painful spots where cancer has spread to the bone. The goal is to treat the pain more precisely and see if this image-guided approach works well.
This study uses a detailed bone scan (SPECT/CT) to better understand what is causing bone problems, such as cancer spread or arthritis. It helps doctors tell the difference between these two causes for better treatment.
This trial compares two types of PET/CT scans to see which one better finds lesions (areas of disease) in people with newly diagnosed multiple myeloma. If you qualify, you may help doctors choose the most useful scan to guide care.
Hear when a new Bone Metastases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.